Related Experiment Video
Updated: Jun 22, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
[Calciphylaxis]
Knud Bonnet Yderstraede1, Ole Clemmensen, Anna Marie Nielsen
1Odense Universitetshospital, Endokrinologisk Afdeling M, DK - 5000 Odense C. Knud.yderstraede@ouh.regionsyddanmark.dk
Insights
Calciphylaxis, a severe condition affecting patients on chronic hemodialysis, involves tissue necrosis and arterial occlusion. Early intervention and optimized calcium-phosphorus control may prevent this high-mortality disorder.
Area of Science:
- Vascular Medicine
- Nephrology
- Dermatology
Context:
- Calciphylaxis affects 1-4% of patients undergoing chronic hemodialysis.
- This condition is characterized by ischemic, nodular necrosis of subcutaneous tissue and vascular occlusion.
- High mortality rates are linked to co-morbidities in affected patients.
Purpose:
- To highlight the critical nature of calciphylaxis in hemodialysis patients.
- To emphasize the potential for prevention through metabolic control.
- To underscore the need for focused research and therapeutic development.
Summary:
- Calciphylaxis presents as subcutaneous tissue necrosis and small to medium artery occlusion.
- Optimizing calcium-phosphorus metabolism is suggested as a preventive strategy.
- Emerging therapies offer new hope for managing this severe condition.
Impact:
- Improved patient outcomes through timely diagnosis and treatment.
- Reduced mortality associated with calciphylaxis.
- Advancement of therapeutic options for a challenging clinical entity.
Abstract:
Calciphylaxis is a serious condition including ischaemic, nodular necrosis of the subcutaneous tissue and occlusion of small and medium-sized arteries. The prevalence of calciphylaxis among patients on chronic haemodialysis constitutes 1-4 percent. The condition is associated with high mortality due to co-morbidity. Calciphylaxis seems to be preventable by optimized control of calcium-phosphorous metabolism in susceptible individuals. New and promising therapies are evolving. It is important to focus on this condition in order to provide the relevant therapy to the affected cases.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Urinary Tract Calculi I: Introduction

